Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carotid Revascularization vs Best Medical Treatment for Asymptomatic Carotid Stenosis
NCT05623904Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Oct 2022
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Xuanwu Hospital. Primary endpoint: Any Periprocedural Stroke, Myocardial Infarction, or Death During 1 month Peri-procedural Period, and Postprocedural Ipsilateral Stroke 1 to 12-months. Started Oct 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05623904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05623904.